Equities researchers at StockNews.com started coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “buy” rating on the stock.
LFVN stock opened at $4.89 on Thursday. The firm has a market capitalization of $61.57 million, a PE ratio of 6.99 and a beta of 1.39. LifeVantage has a twelve month low of $3.80 and a twelve month high of $8.63. The stock has a 50-day simple moving average of $4.27 and a two-hundred day simple moving average of $5.20.
LifeVantage (NASDAQ:LFVN – Get Rating) last issued its quarterly earnings results on Tuesday, May 3rd. The company reported $0.12 earnings per share (EPS) for the quarter. The firm had revenue of $50.00 million during the quarter. LifeVantage had a return on equity of 27.19% and a net margin of 4.49%. During the same quarter last year, the business posted $0.20 EPS. As a group, sell-side analysts expect that LifeVantage will post 0.54 EPS for the current fiscal year.
About LifeVantage (Get Rating)
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes.
- Get a free copy of the StockNews.com research report on LifeVantage (LFVN)
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
- The Rebound In Winnabego Is On
- Global Events Could Be A Boon For Potash Stocks
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.